Triple-negative breast cancer (TNBC), defined by a lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, is a high-grade phenotype of breast cancer with a poor prognosis [1, 2]. Here, ERBB2 is linked to triple-negative breast carcinoma.